4 COVID Cell Therapies and the Companies That Are Making Them

2 min read

The COVID-19 pandemic is one of modern medicine’s greatest challenges with 20 million (and counting) confirmed cases worldwide. Drugs in development to treat infections span small molecules, vaccines, and antibody-based therapies. Apart from these modalities, scientists are also using regenerative medicine paradigms as inspiration for new cell-based therapies to combat COVID-19. Earlier in the year, a small pilot study in China showed that COVID patients who were infused with mesenchymal stem cells, or MSCs, had improved outcomes — perhaps due to the ability of stem cells to modulate the immune system. The truth is, we don’t fully know and much…...

This article is free to read

Login to read the full article


By subscribing to our main site, you will also be subscribed to DDIntel - our regular letter showcasing our featured articles and applications.

Tara Fernandez Tara Fernandez is a PhD-qualified Cell Biologist who works in marketing disruptive technologies in the biotechnology industry. Tara reports on innovation and trends in health tech, drug discovery, and more. Follow Tara on Twitter @DrTFern.